Lab Supply Ipamorelin 170851-70-4 for Bodybuilding with GMP Certificate
Ipamorelin is a penta-peptide hormone
(Aib-His-D-2-Nal-D-Phe-Lys-NH2), a hormone secretagogue and a small
molecule ghrelin mimetic developed by Novo Nordisk. Ipamorelin belongs
to the most recent generation of GHRPs and causes significant release of
hormone. Similar to GHRP-6 and GHRP-2, it suppresses somatostatin and
increases the stimulation and release of Hormone (GH) from the anterior
pituitary. Currently, there are few clinical trials involving
Ipamorelin, which were first being studied in the 90s. Somatotropes are
the cells that are responsible for producing and releaseing GH.
Ipamorelin Reviews
Ipamorelin is a fascinating new muscle building discovery that is
getting a lot of attention in the bodybuilding world. It is a synthetic
peptide that has powerful GH releasing properties. And these GH
releasing properties are what is of interest to athletes and
bodybuilders since they can make a tremendous difference in the amount
of muscle you can grow and how quickly you burn fat.
Ipamorelin has been shown to be both highly potent and very
selective in vivo and vitro situations, and has also demonstrated good
safety and tolerability in human clinical studies.
Research has shown that Ipamorelin is hormone specific which means
that the pituitary hormones such as cortisol are unaffected. In one
study, it was found that young female adult rats had increased bone mass
due to 12 weeks of treatment with ipamorelin. This peptide compared to
other Hormone Releasing Peptides ensures the benefits without having to
deal with possible negative side effects.
Ipamorelin in theory may increase Acetylchloine or Cortisol when
used in higher dosages. However, and increase in Acetylchloine or
Cortisol is even more likely with GHRP-2 and GHRP-6. In fact, in the
case of Ipamorelin, there was little to no rise in Acetylcholine and
Cortisol blood plasma levels even at injections more than 200 times
higher than the effective dosage for comparable GH release.
This clearly proves that Ipamorelin is the first successful GHRP
receptor agonist or chemical that binds to a receptor of a cell and
triggers a response by that cell with a specific selectivity for the
promotion of GH release by itself.
Another advantage to Ipamorelin is that it doesn't cause sudden
spikes in prolactin or cortisol as does GHRP-2 and GHRP-6. Ipamorelin is
slower in its delivery unlike GHRP's which spike GH levels at a more
rapid rate. The slower release is more natural and has a more sustained
effect.
The Wall